These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 7788106

  • 21. Vigabatrin use in 72 patients with drug-resistant epilepsy.
    Buchanan N.
    Seizure; 1994 Sep; 3(3):191-6. PubMed ID: 8000713
    [Abstract] [Full Text] [Related]

  • 22. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
    Bélanger S, Coulombe G, Carmant L.
    Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Vigabatrin in the treatment of infantile spasms.
    Koo B.
    Pediatr Neurol; 1999 Feb; 20(2):106-10. PubMed ID: 10082337
    [Abstract] [Full Text] [Related]

  • 30. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.
    Vigevano F, Cilio MR.
    Epilepsia; 1997 Dec; 38(12):1270-4. PubMed ID: 9578521
    [Abstract] [Full Text] [Related]

  • 31. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 32. [Efficacy and tolerability of vigabatrin in West syndrome].
    Moraes MH, Montenegro MA, Franzon RC, Avila JO, Guerreiro MM.
    Arq Neuropsiquiatr; 2005 Jun; 63(2B):469-73. PubMed ID: 16059600
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Inappropriate use of carbamazepine and vigabatrin in typical absence seizures.
    Parker AP, Agathonikou A, Robinson RO, Panayiotopoulos CP.
    Dev Med Child Neurol; 1998 Aug; 40(8):517-9. PubMed ID: 9746003
    [Abstract] [Full Text] [Related]

  • 35. Diagnostic issues and treatment of cryptogenic or symptomatic generalized epilepsies.
    Ohtsuka Y, Yoshinaga H, Kobayashi K, Ogino T, Oka M, Ito M.
    Epilepsy Res; 2006 Aug; 70 Suppl 1():S132-40. PubMed ID: 16815681
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Vigabatrin.
    Guberman A.
    Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S13-7. PubMed ID: 8951215
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.